MicroRNA‐based biomarkers for diagnosis of non‐small cell lung cancer (NSCLC)

Abstract

Lung cancer is a heterogeneous disease and develops from complex aberrations. Integrating sputum and plasma miRNAs has higher accuracy than when they are used alone.